MIRA Pharmaceuticals (MIRA) EBITDA Yield: History & Chart

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T19:07:23.511Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:07:23.511Z.

Quote observation: 2026-10-06T19:03:09.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -9,401,410
Quote market capitalization: 30,247,498
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 3,609,442

FMP input reference: d441fe8f086afba93fb8397567d44bfe794a39cd606e17fb54204e4f45075d8b

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

MIRA EBITDA Yield Metrics

EBITDA YIELD

N/A

MIRA Competitors' EBITDA Yield

MIRA

MIRA Pharmaceuticals, Inc.

Current

Market Cap

$30.25M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BYSI

BeyondSpring Inc.

vs MIRA

Market Cap

$30.33M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRVO

CervoMed Inc.

vs MIRA

Market Cap

$30.60M

EBITDA Yield

N/A

TTM Avg

392.49%

3Y Avg

233.09%

5Y Avg

233.09%

CNTX

Context Therapeutics Inc.

vs MIRA

Market Cap

$29.83M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDXH

MDxHealth S.A.

vs MIRA

Market Cap

$30.67M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

QUCY

Quantum Cyber N.V.

vs MIRA

Market Cap

$29.71M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SCYX

SCYNEXIS, Inc.

vs MIRA

Market Cap

$30.94M

EBITDA Yield

N/A

TTM Avg

119.50%

3Y Avg

119.50%

5Y Avg

119.50%

GRDX

GridAI Technologies Corp.

vs MIRA

Market Cap

$29.74M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NSYS

Nortech Systems Incorporated

vs MIRA

Market Cap

$31.44M

EBITDA Yield

7.80%

TTM Avg

3.91%

3Y Avg

10.09%

5Y Avg

10.18%

TVGN

Tevogen Bio Holdings Inc.

vs MIRA

Market Cap

$28.94M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
MIRA Pharmaceuticals, Inc. (MIRA)	$30.25M	N/A	N/A	N/A	N/A
BeyondSpring Inc. (BYSI)vs ›	$30.33M	N/A	N/A	N/A	N/A
CervoMed Inc. (CRVO)vs ›	$30.60M	N/A	392.49%	233.09%	233.09%
Context Therapeutics Inc. (CNTX)vs ›	$29.83M	N/A	N/A	N/A	N/A
MDxHealth S.A. (MDXH)vs ›	$30.67M	N/A	N/A	N/A	N/A
Quantum Cyber N.V. (QUCY)vs ›	$29.71M	N/A	N/A	N/A	N/A
SCYNEXIS, Inc. (SCYX)vs ›	$30.94M	N/A	119.50%	119.50%	119.50%
GridAI Technologies Corp. (GRDX)vs ›	$29.74M	N/A	N/A	N/A	N/A
Nortech Systems Incorporated (NSYS)vs ›	$31.44M	7.80%	3.91%	10.09%	10.18%
Tevogen Bio Holdings Inc. (TVGN)vs ›	$28.94M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

MIRA EBITDA Yield Metrics

MIRA Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics